Ovalbumin induces natural killer cells to secrete Th2 cytokines IL‑5 and IL‑13 in a mouse model of asthma

Chen,Zhangbo; Wang,Lu

doi:10.3892/mmr.2019.9966

Ovalbumin induces natural killer cells to secrete Th2 cytokines IL‑5 and IL‑13 in a mouse model of asthma

Authors:
- Zhangbo Chen
- Lu Wang
View Affiliations

Affiliations: Department of Pathogen Biology and Immunology, Shenzhen University School of Medicine, Shenzhen, Guangdong 518060, P.R. China, Department of Physiology and Chinese‑German Stem Cell Center, Tongji Medical College, Huazhong University of Science and Technology, The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, Hubei 430030, P.R. China
Published online on: February 19, 2019 https://doi.org/10.3892/mmr.2019.9966
Pages: 3210-3216
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Asthma is a chronic lung disease characterized by an imbalance of T‑helper (Th)1/Th2 cells and their cytokine profiles. Natural killer (NK) cells constitute a considerable subset of the lymphocyte population in the lungs, and provide protection against respiratory infection by fungi, bacteria and viruses. However, the mechanism by which NK cells are involved in asthma remains to be fully elucidated. The present study analyzed the dynamic changes of NK cells and their subsets during the development of the ovalbumin (OVA)‑induced allergic airway response. Lung tissues were histologically examined for cell infiltration and mucus hypersecretion. The number, activity and cytokine‑secreting ability of NK cells was determined by flow cytometry. The results showed that the percentage of NK cells in the lung was decreased following OVA sensitization and challenge. However, NK cells exhibited enhanced activity and secreted more Th2 cytokines (IL‑5 and IL‑13) following OVA challenge. Furthermore, the proportion of CD11b‑ NK subsets increased with the development of asthma, and CD11b‑ CD27‑ NK cells were the primary NK subset producing Th2 cytokines. These findings suggest that, although NK cells are not the crucial type of lymphocytes involved in asthma, OVA induces NK cells to secrete Th2 cytokines that may be involved in the pathogenesis of asthma.

View Figures

View References

1	Jayasinghe H, Kopsaftis Z and Carson K: Asthma bronchiale and exercise-induced bronchoconstriction. Respiration. 89:505–512. 2015. View Article : Google Scholar : PubMed/NCBI
2	Reddel HK and Levy ML; Global Initiative for Asthma Scientific Committee and Dissemination and Implementation Committee, : The GINA asthma strategy report: What's new for primary care? NPJ Prim Care Respir Med. 25:150502015. View Article : Google Scholar : PubMed/NCBI
3	Becker AB and Abrams EM: Asthma guidelines: The global initiative for asthma in relation to national guidelines. Curr Opin Allergy Clin Immunol. 17:99–103. 2017. View Article : Google Scholar : PubMed/NCBI
4	Fajt ML and Wenzel SE: Asthma phenotypes and the use of biologic medications in asthma and allergic disease: The next steps toward personalized care. J Allergy Clin Immunol. 135:299–311. 2015. View Article : Google Scholar : PubMed/NCBI
5	Wenzel SE: Asthma phenotypes: The evolution from clinical to molecular approaches. Nat Med. 18:716–725. 2012. View Article : Google Scholar : PubMed/NCBI
6	Yu S, Kim HY, Chang YJ, DeKruyff RH and Umetsu DT: Innate lymphoid cells and asthma. J Allergy Clin Immunol. 133:943–951. 2014. View Article : Google Scholar : PubMed/NCBI
7	DeKruyff RH, Yu S, Kim HY and Umetsu DT: Innate immunity in the lung regulates the development of asthma. Immunol Rev. 260:235–248. 2014. View Article : Google Scholar : PubMed/NCBI
8	Kim HY, DeKruyff RH and Umetsu DT: The many paths to asthma: Phenotype shaped by innate and adaptive immunity. Nat Immunol. 11:577–584. 2010. View Article : Google Scholar : PubMed/NCBI
9	McKenzie AN: Type-2 innate lymphoid cells in asthma and allergy. Ann Am Thorac Soc. 11 (Suppl 5):S263–S270. 2014. View Article : Google Scholar : PubMed/NCBI
10	Campbell KS and Hasegawa J: Natural killer cell biology: An update and future directions. J Allergy Clin Immunol. 132:536–544. 2013. View Article : Google Scholar : PubMed/NCBI
11	Varchetta S, Oliviero B, Mavilio D and Mondelli MU: Different combinations of cytokines and activating receptor stimuli are required for human natural killer cell functional diversity. Cytokine. 62:58–63. 2013. View Article : Google Scholar : PubMed/NCBI
12	Ndhlovu LC, Lopez-Vergès S, Barbour JD, Jones RB, Jha AR, Long BR, Schoeffler EC, Fujita T, Nixon DF and Lanier LL: Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood. 119:3734–3743. 2012. View Article : Google Scholar : PubMed/NCBI
13	Messaoudene M, Fregni G, Fourmentraux-Neves E, Chanal J, Maubec E, Mazouz-Dorval S, Couturaud B, Girod A, Sastre-Garau X, Albert S, et al: Mature cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma. Cancer Res. 74:81–92. 2014. View Article : Google Scholar : PubMed/NCBI
14	Chiossone L, Chaix J, Fuseri N, Roth C, Vivier E and Walzer T: Maturation of mouse NK cells is a 4-stage developmental program. Blood. 113:5488–5496. 2009. View Article : Google Scholar : PubMed/NCBI
15	Holmes ML, Huntington ND, Thong RP, Brady J, Hayakawa Y, Andoniou CE, Fleming P, Shi W, Smyth GK, Degli-Esposti MA, et al: Peripheral natural killer cell maturation depends on the transcription factor Aiolos. EMBO J. 33:2721–2734. 2014. View Article : Google Scholar : PubMed/NCBI
16	Chen Z, Chen X, Xu Y, Xiong P, Fang M, Tan Z, Gong F and Zheng F: Collagenase digestion down-regulates the density of CD27 on lymphocytes. J Immunol Methods. 413:57–61. 2014. View Article : Google Scholar : PubMed/NCBI
17	Allan RS, Zueva E, Cammas F, Schreiber HA, Masson V, Belz GT, Roche D, Maison C, Quivy JP, Almouzni G and Amigorena S: An epigenetic silencing pathway controlling T helper 2 cell lineage commitment. Nature. 487:249–253. 2012. View Article : Google Scholar : PubMed/NCBI
18	Gray LEK and Sly PD: Update in asthma 2017. Am J Respir Crit Care Med. 197:1108–1115. 2018. View Article : Google Scholar : PubMed/NCBI
19	Poli A, Michel T, Patil N and Zimmer J: Revisiting the functional impact of NK cells. Trends Immunol. 39:460–472. 2018. View Article : Google Scholar : PubMed/NCBI
20	Peters SP: Asthma phenotypes: Nonallergic (intrinsic) asthma. J Allergy Clin Immunol Pract. 2:650–652. 2014. View Article : Google Scholar : PubMed/NCBI
21	Schatz M and Rosenwasser L: The allergic asthma phenotype. J Allergy Clin Immunol Pract. 2:645–649. 2014. View Article : Google Scholar : PubMed/NCBI
22	Steinke JW and Borish L: Th2 cytokines and asthma. Interleukin-4: Its role in the pathogenesis of asthma and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir Res. 2:66–70. 2001. View Article : Google Scholar : PubMed/NCBI
23	Munitz A, Brandt EB, Mingler M, Finkelman FD and Rothenberg ME: Distinct roles for IL-13 and IL-4 via IL-13 receptor alpha1 and the type II IL-4 receptor in asthma pathogenesis. Proc Natl Acad Sci USA. 105:7240–7245. 2008. View Article : Google Scholar : PubMed/NCBI
24	Rosenwasser LJ and Rothenberg ME: IL-5 pathway inhibition in the treatment of asthma and Churg-Strauss syndrome. J Allergy Clin Immunol. 125:1245–1246. 2010. View Article : Google Scholar : PubMed/NCBI
25	Ingram JL and Kraft M: IL-13 in asthma and allergic disease: Asthma phenotypes and targeted therapies. J Allergy Clin Immunol. 130:829–844. 2012. View Article : Google Scholar : PubMed/NCBI
26	Lambrecht BN and Hammad H: Asthma and coagulation. N Engl J Med. 369:1964–1966. 2013. View Article : Google Scholar : PubMed/NCBI
27	van Helden MJ and Lambrecht BN: Dendritic cells in asthma. Curr Opin Immunol. 25:745–754. 2013. View Article : Google Scholar : PubMed/NCBI
28	Deniz G, van de Veen W and Akdis M: Natural killer cells in patients with allergic diseases. J Allergy Clin Immunol. 132:527–535. 2013. View Article : Google Scholar : PubMed/NCBI
29	Korsgren M, Persson CG, Sundler F, Bjerke T, Hansson T, Chambers BJ, Hong S, Van Kaer L, Ljunggren HG and Korsgren O: Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J Exp Med. 189:553–562. 1999. View Article : Google Scholar : PubMed/NCBI
30	Ple C, Barrier M, Amniai L, Marquillies P, Bertout J, Tsicopoulos A, Walzer T, Lassalle P and Duez C: Natural killer cells accumulate in lung-draining lymph nodes and regulate airway eosinophilia in a murine model of asthma. Scand J Immunol. 72:118–127. 2010. View Article : Google Scholar : PubMed/NCBI
31	Mathias CB, Guernsey LA, Zammit D, Brammer C, Wu CA, Thrall RS and Aguila HL: Pro-inflammatory role of natural killer cells in the development of allergic airway disease. Clin Exp Allergy. 44:589–601. 2014. View Article : Google Scholar : PubMed/NCBI
32	Perricone R, Perricone C, De Carolis C and Shoenfeld Y: NK cells in autoimmunity: A two-edg'd weapon of the immune system. Autoimmun Rev. 7:384–390. 2008. View Article : Google Scholar : PubMed/NCBI
33	Haeberlein S, Sebald H, Bogdan C and Schleicher U: IL-18, but not IL-15, contributes to the IL-12-dependent induction of NK-cell effector functions by Leishmania infantum in vivo. Eur J Immunol. 40:1708–1717. 2010. View Article : Google Scholar : PubMed/NCBI
34	Hoshino T, Winkler-Pickett RT, Mason AT, Ortaldo JR and Young HA: IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma. J Immunol. 162:51–59. 1999.PubMed/NCBI
35	McDermott JR, Humphreys NE, Forman SP, Donaldson DD and Grencis RK: Intraepithelial NK cell-derived IL-13 induces intestinal pathology associated with nematode infection. J Immunol. 175:3207–3213. 2005. View Article : Google Scholar : PubMed/NCBI
36	Aktas E, Akdis M, Bilgic S, Disch R, Falk CS, Blaser K, Akdis C and Deniz G: Different natural killer (NK) receptor expression and immunoglobulin E (IgE) regulation by NK1 and NK2 cells. Clin Exp Immunol. 140:301–309. 2005. View Article : Google Scholar : PubMed/NCBI
37	Fahy JV: Type 2 inflammation in asthma-present in most, absent in many. Nat Rev Immunol. 15:57–65. 2015. View Article : Google Scholar : PubMed/NCBI
38	Holgate ST: Innate and adaptive immune responses in asthma. Nat Med. 18:673–683. 2012. View Article : Google Scholar : PubMed/NCBI
39	Sceneay J, Chow MT, Chen A, Halse HM, Wong CS, Andrews DM, Sloan EK, Parker BS, Bowtell DD, Smyth MJ and Möller A: Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. Cancer Res. 72:3906–3911. 2012. View Article : Google Scholar : PubMed/NCBI
40	Yanagisawa K, Exley MA, Jiang X, Ohkochi N, Taniguchi M and Seino K: Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide. Cancer Res. 66:11441–11446. 2006. View Article : Google Scholar : PubMed/NCBI
41	Clinthorne JF, Beli E, Duriancik DM and Gardner EM: NK cell maturation and function in C57BL/6 mice are altered by caloric restriction. J Immunol. 190:712–722. 2013. View Article : Google Scholar : PubMed/NCBI
42	Mao Y, Sarhan D, Steven A, Seliger B, Kiessling R and Lundqvist A: Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity. Clin Cancer Res. 20:4096–4106. 2014. View Article : Google Scholar : PubMed/NCBI